Collegium Reports Third Quarter Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- Wall Street rallies as AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips below $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Qatar Investment Authority targets $20B partnership with JPMorgan - Bloomberg
- Wall Street rallies as AI optimism reignites and Treasury yields retreat
Collegium Pharma (COLL) Misses Q3 EPS by 16c
November 8, 2018 4:35 PM ESTCollegium Pharma (NASDAQ: COLL) reported Q3 EPS of ($0.50), $0.16 worse than the analyst estimate of ($0.34). Revenue for the quarter came in at $70.2 million versus the consensus estimate of $74.79 million.
For earnings history and earnings-related data on Collegium Pharma (COLL) click here.
... More